ArticleTrials2025
Impact of personlized exercise prescription on muscle mass, physical function, and quality of life in postoperative pancreatic cancer patients undergoing da Vinci robotic surgery: a randomized controlled trial protocol.
Article in Trials, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
backgroundPancreatic cancer is characterized by a 5-year survival rate of less than 12%, primarily because of challenges in early diagnosis, which has resulted in a generally poor prognosis for patients. With ongoing advancements in diagnostic and surgical technologies, there is an increasing focus on enhancing the postoperative quality of life for individuals with pancreatic cancer. Although existing research suggests that exercise interventions are safe for this patient population, definitive evidence regarding their efficacy remains insufficient. Consequently, this study aims to conduct a randomized controlled trial to assess the safety and efficacy of exercise interventions in enhancing muscle mass, physical function, and quality of life among patients who have undergone surgery for pancreatic cancer.
methodsA total of 168 eligible postoperative pancreatic cancer patients will be enrolled and randomly allocated in a 1:2 ratio to either the intervention group or the control group. Participants in the intervention group will receive a personalized exercise prescription for a duration of 16 weeks, whereas participants in the control group will not receive any specific exercise prescription or intervention. The primary outcomes of this study include Changes in muscle mass, specifically the skeletal muscle index and density, from baseline to week 16, as well as assessments of physical function using the 6-Minute Walk Test (6MWT) and evaluations of quality of life through standardized scale scores. Secondary outcomes comprise assessments using the Functional Assessment of Cancer Therapy Fatigue Scale (FACT-F), the Hospital Anxiety and Depression Scale (HADS), and the Pittsburgh Sleep Quality Index (PSQI). Measurements of outcome indicators other than muscle mass will be conducted at weeks 0, 4, and 12, respectively. DISCUSSION: The impact of the personalized exercise prescription intervention will be evaluated through alterations in primary and secondary outcome indicators at both the 4-week intervention mark and the 12-week follow-up period. This trial aims to offer novel clinical insights into the efficacy of personalized exercise prescriptions in enhancing muscle mass, physical function, and quality of life among postoperative pancreatic cancer patients.
trial registrationClinical Trial Registry-China ChiCTR2500098709. Registered on 12 March 2025.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.